Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Department of Preventive Medicine, University of Mississippi Medical Center, Jackson.
JAMA Cardiol. 2017 Sep 1;2(9):986-994. doi: 10.1001/jamacardio.2017.2498.
Besides age, other discriminators of atherosclerotic cardiovascular disease (ASCVD) risk are needed in older adults.
To examine the predictive ability of coronary artery calcium (CAC) score vs age for incident ASCVD and how risk prediction changes by adding CAC score and removing only age from prediction models.
DESIGN, SETTING, AND PARTICIPANTS: We conducted an analysis of pooled US population-based studies, including the Framingham Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study. Results were compared with 2 European cohorts, the Rotterdam Study and the Heinz Nixdorf Recall Study. Participants underwent CAC scoring between 1998 and 2006 using cardiac computed tomography. The participants included adults older than 60 years without known ASCVD at baseline.
Coronary artery calcium scores.
Incident ASCVD events including coronary heart disease (CHD) and stroke.
The study included 4778 participants from 3 US cohorts, with a mean age of 70.1 years; 2582 (54.0%) were women, and 2431 (50.9%) were nonwhite. Over 11 years of follow-up (44 152 person-years), 405 CHD and 228 stroke events occurred. Coronary artery calcium score (vs age) had a greater association with incident CHD (C statistic, 0.733 vs 0.690; C statistics difference, 0.043; 95% CI of difference, 0.009-0.075) and modestly improved prediction of incident stroke (C statistic, 0.695 vs 0.670; C statistics difference, 0.025; 95% CI of difference, -0.015 to 0.064). Adding CAC score to models including traditional cardiovascular risk factors, with only age being removed, provided improved discrimination for incident CHD (C statistic, 0.735 vs 0.703; C statistics difference, 0.032; 95% CI of difference, 0.002-0.062) but not for stroke. Coronary artery calcium score was more likely than age to provide higher category-free net reclassification improvement among participants who experienced an ASCVD event (0.390; 95% CI, 0.312-0.467 vs 0.08; 95% CI -0.001 to 0.181) and to result in more accurate reclassification of risk for ASCVD events among these individuals. The findings were similar in the 2 European cohorts (n = 4990).
Coronary artery calcium may be an alternative marker besides age to better discriminate between lower and higher CHD risk in older adults. Whether CAC score can assist in guiding the decision to initiate statin treatment for primary prevention in older adults requires further investigation.
除了年龄,还需要其他区分动脉粥样硬化性心血管疾病(ASCVD)风险的指标来评估老年人的风险。
研究冠状动脉钙(CAC)评分与年龄对ASCVD事件的预测能力,以及通过增加 CAC 评分和仅从预测模型中去除年龄,风险预测会如何改变。
设计、设置和参与者:我们对美国基于人群的多个研究进行了分析,包括弗雷明汉心脏研究、多民族动脉粥样硬化研究和心血管健康研究。结果与两个欧洲队列(鹿特丹研究和海因茨·尼克斯多夫回顾研究)进行了比较。参与者在 1998 年至 2006 年间接受了心脏计算机断层扫描的 CAC 评分。研究包括基线时无已知 ASCVD 的年龄在 60 岁以上的成年人。
冠状动脉钙评分。
包括冠心病(CHD)和中风在内的 ASCVD 事件。
这项研究包括来自 3 个美国队列的 4778 名参与者,平均年龄为 70.1 岁;2582 名(54.0%)为女性,2431 名(50.9%)为非白人。在 11 年的随访期间(44152 人年),发生了 405 例 CHD 和 228 例中风事件。与年龄相比,CAC 评分(vs 年龄)与 CHD 事件的发生有更强的关联(C 统计量,0.733 vs 0.690;C 统计量差异,0.043;95%CI 差值,0.009-0.075),并且对中风事件的预测有适度改善(C 统计量,0.695 vs 0.670;C 统计量差异,0.025;95%CI 差值,-0.015 至 0.064)。将 CAC 评分添加到包含传统心血管危险因素的模型中,仅去除年龄,可以提高 CHD 事件的预测准确性(C 统计量,0.735 vs 0.703;C 统计量差异,0.032;95%CI 差值,0.002-0.062),但对中风无影响。与年龄相比,CAC 评分更有可能为经历 ASCVD 事件的参与者提供更高的无分类净重新分类改善(0.390;95%CI,0.312-0.467 vs 0.08;95%CI -0.001 至 0.181),并能更准确地重新分类这些个体的 ASCVD 事件风险。在这两个欧洲队列(n=4990)中也发现了类似的结果。
除了年龄,冠状动脉钙可能是另一种标志物,可以更好地区分老年人的 CHD 低风险和高风险。CAC 评分是否可以帮助指导在老年人中进行一级预防的他汀类药物治疗决策,还需要进一步研究。